| Center For Hospice & Palliative Care 1200 Westwood Dr, Hamilton, MT, 59840 | |
| (406) 375-6503 |
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
By developing the first statistical model to finely characterize how ketamine anesthesia affects the brain, a team of researchers at MIT's Picower Institute for Learning and Memory and Massachusetts General Hospital have laid new groundwork for three advances: understanding how ketamine induces anesthesia; monitoring the unconsciousness of patients in surgery; and applying a new method of analyzing brain activity.
The American Heart Association/American Stroke Association's Get With The Guidelines®–Stroke successfully measured the quality of stroke prevention and care in a nationwide stroke registry in Taiwan and identified important areas for improvement.
Like anyone who writes regularly about what passes for economic and fiscal debate in American politics, I've developed a strong tolerance for nonsense. After all, if I got upset every time powerful people were illogical and/or dishonest, I'd spend every waking hour in a state of raging despair. ... if you're serious about deficits, you shouldn't be pinching pennies now; you should be looking for ways to rein in health spending over the long term.
› Verified 5 days ago
| Name | Center For Hospice & Palliative Care |
|---|---|
| Location | 1200 Westwood Dr, Hamilton, Montana |
| Hospice ID | 271508 |
| Category | Part of a hospital |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 400 |
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
By developing the first statistical model to finely characterize how ketamine anesthesia affects the brain, a team of researchers at MIT's Picower Institute for Learning and Memory and Massachusetts General Hospital have laid new groundwork for three advances: understanding how ketamine induces anesthesia; monitoring the unconsciousness of patients in surgery; and applying a new method of analyzing brain activity.
The American Heart Association/American Stroke Association's Get With The Guidelines®–Stroke successfully measured the quality of stroke prevention and care in a nationwide stroke registry in Taiwan and identified important areas for improvement.
Like anyone who writes regularly about what passes for economic and fiscal debate in American politics, I've developed a strong tolerance for nonsense. After all, if I got upset every time powerful people were illogical and/or dishonest, I'd spend every waking hour in a state of raging despair. ... if you're serious about deficits, you shouldn't be pinching pennies now; you should be looking for ways to rein in health spending over the long term.
› Verified 5 days ago
| NPI Number | 1427151828 |
| Organization Name | Marcus Daly Memorial Hospital Corporation |
| Address | 1200 Westwood Dr Hamilton, Montana, 59840 |
| Phone Number | (406)363-6503 |
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
By developing the first statistical model to finely characterize how ketamine anesthesia affects the brain, a team of researchers at MIT's Picower Institute for Learning and Memory and Massachusetts General Hospital have laid new groundwork for three advances: understanding how ketamine induces anesthesia; monitoring the unconsciousness of patients in surgery; and applying a new method of analyzing brain activity.
The American Heart Association/American Stroke Association's Get With The Guidelines®–Stroke successfully measured the quality of stroke prevention and care in a nationwide stroke registry in Taiwan and identified important areas for improvement.
Like anyone who writes regularly about what passes for economic and fiscal debate in American politics, I've developed a strong tolerance for nonsense. After all, if I got upset every time powerful people were illogical and/or dishonest, I'd spend every waking hour in a state of raging despair. ... if you're serious about deficits, you shouldn't be pinching pennies now; you should be looking for ways to rein in health spending over the long term.
› Verified 5 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.3 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 88.3 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
By developing the first statistical model to finely characterize how ketamine anesthesia affects the brain, a team of researchers at MIT's Picower Institute for Learning and Memory and Massachusetts General Hospital have laid new groundwork for three advances: understanding how ketamine induces anesthesia; monitoring the unconsciousness of patients in surgery; and applying a new method of analyzing brain activity.
The American Heart Association/American Stroke Association's Get With The Guidelines®–Stroke successfully measured the quality of stroke prevention and care in a nationwide stroke registry in Taiwan and identified important areas for improvement.
Like anyone who writes regularly about what passes for economic and fiscal debate in American politics, I've developed a strong tolerance for nonsense. After all, if I got upset every time powerful people were illogical and/or dishonest, I'd spend every waking hour in a state of raging despair. ... if you're serious about deficits, you shouldn't be pinching pennies now; you should be looking for ways to rein in health spending over the long term.
› Verified 5 days ago
| Home Health Aides | 1 |
| Counselors | 0.25 |
| Licensed Practical or Vocational Nurses | 5 |
| Medical Social Workers | 0.75 |
| Physicians | 0.5 |
| Registered Nurses | 4 |
| Other Personnel | 4 |
| Total Employees | 15.5 |
|---|
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
By developing the first statistical model to finely characterize how ketamine anesthesia affects the brain, a team of researchers at MIT's Picower Institute for Learning and Memory and Massachusetts General Hospital have laid new groundwork for three advances: understanding how ketamine induces anesthesia; monitoring the unconsciousness of patients in surgery; and applying a new method of analyzing brain activity.
The American Heart Association/American Stroke Association's Get With The Guidelines®–Stroke successfully measured the quality of stroke prevention and care in a nationwide stroke registry in Taiwan and identified important areas for improvement.
Like anyone who writes regularly about what passes for economic and fiscal debate in American politics, I've developed a strong tolerance for nonsense. After all, if I got upset every time powerful people were illogical and/or dishonest, I'd spend every waking hour in a state of raging despair. ... if you're serious about deficits, you shouldn't be pinching pennies now; you should be looking for ways to rein in health spending over the long term.
› Verified 5 days ago
| Others | 27 |
| Total Volunteers | 27 |
|---|
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
By developing the first statistical model to finely characterize how ketamine anesthesia affects the brain, a team of researchers at MIT's Picower Institute for Learning and Memory and Massachusetts General Hospital have laid new groundwork for three advances: understanding how ketamine induces anesthesia; monitoring the unconsciousness of patients in surgery; and applying a new method of analyzing brain activity.
The American Heart Association/American Stroke Association's Get With The Guidelines®–Stroke successfully measured the quality of stroke prevention and care in a nationwide stroke registry in Taiwan and identified important areas for improvement.
Like anyone who writes regularly about what passes for economic and fiscal debate in American politics, I've developed a strong tolerance for nonsense. After all, if I got upset every time powerful people were illogical and/or dishonest, I'd spend every waking hour in a state of raging despair. ... if you're serious about deficits, you shouldn't be pinching pennies now; you should be looking for ways to rein in health spending over the long term.
› Verified 5 days ago
| Center For Hospice & Palliative Care Location: 1200 Westwood Dr, Hamilton, Montana, 59840 Phone: (406) 375-6503 |